Drug intelligence / Profile preview

bisdemethoxycurcumin

Development stage
Preclinical
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Bisdemethoxycurcumin (BDMC) is a natural curcuminoid found in the rhizomes of *Curcuma longa* (turmeric). As a demethoxy derivative of curcumin, it is characterized by higher chemical stability and potentially superior bioavailability compared to curcumin. BDMC exhibits pleiotropic pharmacological effects, including anti-inflammatory, antioxidant, and antineoplastic activities. In oncology, it has been shown to induce DNA damage and inhibit DNA repair proteins such as BRCA1 and MGMT. Furthermore, it modulates the tumor microenvironment by increasing CD8+ T-cell infiltration and reducing myeloid-derived suppressor cells (MDSCs), showing synergistic potential when combined with PD-1/PD-L1 checkpoint inhibitors. In neurodegenerative research, BDMC has demonstrated potential for Alzheimer's disease by enhancing amyloid-beta phagocytosis through the upregulation of MGAT3 and vitamin D receptors, and by acting as an acetylcholinesterase (AChE) inhibitor.

Other names
Curcumin III1,7-bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione
02

Targets

AcetylcholinesteraseGSK3 (Glycogen synthase kinase 3 beta)BACE1 (Beta-site APP-cleaving enzyme 1)NF-κB

Beyond the preview

Go deeper on bisdemethoxycurcumin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bisdemethoxycurcumin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call